Thomas S, Madaan T, Kamble N, Siddiqui N, Pauletti G, Kotagiri N. Engineered Bacteria Enhance Immunotherapy and Targeted Therapy through Stromal Remodeling of Tumors. Adv Healthc Mater. 2021;:e2101487 pubmed publisher

Ibraheim R, Tai P, Mir A, Javeed N, Wang J, Rodríguez T, et al. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo. Nat Commun. 2021;12:6267 pubmed publisher

Doore S, Subramanian S, Tefft N, Morona R, Teravest M, Parent K. Large metabolic rewiring from small genomic changes between strains of Shigella flexneri. J Bacteriol. 2021;: pubmed publisher

Campellone K, Coulter A. Lambda Red-Mediated Recombination in Shiga Toxin-Producing Escherichia coli. Methods Mol Biol. 2021;2291:145-162 pubmed publisher

Aeschbach L, Dion V. Minimizing carry-over PCR contamination in expanded CAG/CTG repeat instability applications. Sci Rep. 2017;7:18026 pubmed publisher

Hartwich H, Nothwang H. An easy and versatile 2-step protocol for targeted modification and subcloning of DNA from bacterial artificial chromosomes using non-commercial plasmids. BMC Res Notes. 2012;5:156 pubmed publisher

Murphy K, Campellone K. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol. 2003;4:11 pubmed